AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27485028 — Biomarker: PER3 mRNA
Type: Predictive Biomarker (PRD)
Genes: PER3; GIG13
Study 24999075 — Biomarker: Pathological complete response
Type: Surrogate Endpoint (SUR)
Study 22651256 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 11742882 — Biomarker: SLC10A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC10A2; ASBT; ISBT; NTCP2
Study 27214600 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 25271207 — Biomarker: SLC5A2 mRNA
Type: Predictive Biomarker (PRD)
Genes: SLC5A2; SGLT2
Study 27760719 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 27760719 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 23099972 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17903693 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 10025832 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 8862377 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 1606999 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 20685951 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19066755 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 16860894 — Biomarker: EP300 mRNA
Type: Predictive Biomarker (PRD)
Genes: EP300; P300
Study 16860894 — Biomarker: BAD mRNA
Type: Predictive Biomarker (PRD)
Genes: BAD; BBC6; BCL2L8
Study 12564610 — Biomarker: DRD2
Type: Safety Biomarker (SAF)
Study 3544689 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29718556 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27394191 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 24456823 — Biomarker: PIK3CA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: PI3K
Study 19268053 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 3864227 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7741287 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28379486 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 26485128 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 23408577 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 17038641 — Biomarker: Cardiac troponin I
Type: Safety Biomarker (SAF)
Genes: TNNI3; TNNC1
Study 23218961 — Biomarker: DSE mRNA
Type: Predictive Biomarker (PRD)
Genes: DSE; SART2
Study 18398080 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18398080 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 30508408 — Biomarker: SPG7 mRNA
Type: Predictive Biomarker (PRD)
Genes: SPG7; CAR; CMAR; PGN
Study 30508408 — Biomarker: ZFYVE26 mRNA
Type: Predictive Biomarker (PRD)
Genes: ZFYVE26; KIAA0321
Study 30796110 — Biomarker: IDS mRNA
Type: Predictive Biomarker (PRD)
Genes: IDS; SIDS
Study 26125807 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 26125807 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 26125807 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 26125807 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 9354343 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 3006368 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 3006368 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 3006368 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 30139771 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 27193497 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 9667605 — Biomarker: MXD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: MXD1; MAD
Study 2510253 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 28235817 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24436950 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 24436950 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24436950 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 9772600 — Biomarker: Superoxide dismutase Cu-Zn
Type: Pharmacodynamic Biomarker (PDY)
Genes: SOD1
Study 22270487 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19604523 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 19604523 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15047004 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 15047004 — Biomarker: Serum alkaline phosphatase
Type: Surrogate Endpoint (SUR)
Study 15047004 — Biomarker: Intact parathyroid hormone
Type: Predictive Biomarker (PRD)
Study 9679526 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 8024910 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 28042685 — Biomarker: Heat pain threshold
Type: Pharmacodynamic Biomarker (PDY)
Study 7753573 — Biomarker: CPM mRNA
Type: Predictive Biomarker (PRD)
Genes: CPM
Study 7753573 — Biomarker: C6 mRNA
Type: Predictive Biomarker (PRD)
Genes: C6
Study 7753573 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 25519996 — Biomarker: NPEPPS mRNA
Type: Predictive Biomarker (PRD)
Genes: NPEPPS; PSA
Study 24079282 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 24079282 — Biomarker: Cholesteryl ester transfer protein
Type: Pharmacodynamic Biomarker (PDY)
Genes: CETP
Study 17579892 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 7696887 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 22490197 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 22490197 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 9577947 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26089677 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19370040 — Biomarker: HP mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: HP
Study 3026273 — Biomarker: ACE
Type: Safety Biomarker (SAF)
Genes: ACE1; CD143
Study 3026273 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11320359 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 9236502 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 24060199 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19745564 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11502787 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 8484558 — Biomarker: Transmembrane glycoprotein NMB
Type: Pharmacodynamic Biomarker (PDY)
Genes: GPNMB; HGFIN; NMB; UNQ1725/PRO9925
Study 18399768 — Biomarker: SDS mRNA
Type: Predictive Biomarker (PRD)
Genes: SDS; SDH
Study 29739378 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 15811479 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 15811479 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 15811479 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 15811479 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 8974213 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 14621733 — Biomarker: CAT mRNA
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Genes: CAT
Study 26962396 — Biomarker: Reactive oxygen species
Type: Safety Biomarker (SAF)
Study 19817934 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 19817934 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 17047290 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 7957349 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 3310576 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9395363 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 3555585 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 31703750 — Biomarker: GAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAD1; GAD; GAD67
Study 16413753 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 12826020 — Biomarker: CYP2C9 mRNA
Type: Predictive Biomarker (PRD)
Genes: CYP2C9; CYP2C10
Study 25821315 — Biomarker: Hyaluronic acid
Type: Safety Biomarker (SAF)
Study 19767527 — Biomarker: AOX1 mRNA
Type: Predictive Biomarker (PRD)
Genes: AOX1; AO
Study 27014353 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 26843588 — Biomarker: CGA mRNA
Type: Predictive Biomarker (PRD)
Genes: CGA
Study 26843588 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24789057 — Biomarker: DMA mRNA
Type: Predictive Biomarker (PRD)
Genes: DMA; HLA-DMA; hCG_2001572
Study 22447415 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 30641006 — Biomarker: Matrix metalloproteinase 3
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: MMP3; STMY1
Study 2279257 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 6775520 — Biomarker: FAM53B mRNA
Type: Predictive Biomarker (PRD)
Genes: FAM53B; KIAA0140; SMP
Study 19369667 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 8484698 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 28960914 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 21464154 — Biomarker: TLR9
Type: Predictive Biomarker (PRD)
Genes: CD289
Study 18210954 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 8985850 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 31551229 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 31551229 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 26818059 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 17015004 — Biomarker: PPL mRNA
Type: Predictive Biomarker (PRD)
Genes: PPL; KIAA0568
Study 9829381 — Biomarker: Carcinoembryonic antigen CEA
Type: Monitoring Biomarker (MOI)
Genes: CEACAM5; CEA
Study 20473880 — Biomarker: DDIT3 mRNA
Type: Predictive Biomarker (PRD)
Genes: DDIT3; CHOP; CHOP10; GADD153
Study 20473880 — Biomarker: MDM2 mRNA
Type: Predictive Biomarker (PRD)
Genes: MDM2
Study 20473880 — Biomarker: CDK4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CDK4
Study 28867267 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 21944629 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 19857081 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8147630 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 28628970 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28628970 — Biomarker: Serum triglycerides
Type: Surrogate Endpoint (SUR)
Study 28628970 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 28628970 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18972731 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 12717239 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 1608680 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 24383431 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24383431 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 20093665 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16470490 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 7690383 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 29169968 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 29169968 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 23453448 — Biomarker: CD34 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD34
Study 23453448 — Biomarker: Vascular endothelial growth factor receptor 2
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY)
Genes: KDR; FLK1; VEGFR2
Study 23453448 — Biomarker: PTPRC mRNA
Type: Predictive Biomarker (PRD)
Genes: PTPRC; CD45
Study 23453448 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 18347974 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 16418802 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16418802 — Biomarker: Interferon gamma
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Genes: IFNG
Study 9052337 — Biomarker: D-dimer
Type: Safety Biomarker (SAF); Monitoring Biomarker (MOI)
Study 8466349 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 12711121 — Biomarker: GEM mRNA
Type: Predictive Biomarker (PRD)
Genes: GEM; KIR
Study 8832309 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 24903207 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 22420890 — Biomarker: FABP4 mRNA
Type: Predictive Biomarker (PRD)
Genes: FABP4
Study 31278194 — Biomarker: Fibroblast growth factor 23
Type: Pharmacodynamic Biomarker (PDY)
Genes: FGF23; HYPF; UNQ3027/PRO9828
Study 31278194 — Biomarker: Serum phosphate
Type: Pharmacodynamic Biomarker (PDY)
Study 17515857 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 16264051 — Biomarker: Exhaled nitric oxide
Type: Predictive Biomarker (PRD)
Study 15563438 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 28181363 — Biomarker: Gastric inhibitory polypeptide
Type: Pharmacodynamic Biomarker (PDY)
Genes: GIP
Study 8607723 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 8607723 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 25163906 — Biomarker: O-6-methylguanine-DNA-alkyltransferase
Type: Predictive Biomarker (PRD)
Genes: MGMT
Study 19648823 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 19648823 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 17452676 — Biomarker: Estrogen receptor
Type: Predictive Biomarker (PRD)
Genes: ESR1; ESR; NR3A1
Study 24988438 — Biomarker: RALA mRNA
Type: Predictive Biomarker (PRD)
Genes: RALA; RAL
Study 15613828 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 11691521 — Biomarker: LAD1 mRNA
Type: Predictive Biomarker (PRD)
Genes: LAD1; LAD
Study 3436102 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28341782 — Biomarker: ACR mRNA
Type: Predictive Biomarker (PRD)
Genes: ACR; ACRS
Study 28341782 — Biomarker: B-type natriuretic peptide
Type: Safety Biomarker (SAF)
Genes: NPPB
Study 28341782 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 15116086 — Biomarker: Free fatty acids
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 10993625 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 8843757 — Biomarker: Interleukin 6
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: IL6; IFNB2
Study 1346414 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 24018711 — Biomarker: Serum testosterone
Type: Surrogate Endpoint (SUR)
Study 1632401 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 25359382 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23526739 — Biomarker: FOXO1 mRNA
Type: Predictive Biomarker (PRD)
Genes: FOXO1; FKHR; FOXO1A
Study 23526739 — Biomarker: PAX3 mRNA
Type: Predictive Biomarker (PRD)
Genes: PAX3; HUP2
Study 23526739 — Biomarker: PAX7 mRNA
Type: Predictive Biomarker (PRD)
Genes: PAX7; HUP1
Study 17092365 — Biomarker: PYY mRNA
Type: Predictive Biomarker (PRD)
Genes: PYY
Study 10912846 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 25923274 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 23506314 — Biomarker: C-reactive protein
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CRP; PTX1
Study 23506314 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 16810109 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 16571279 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 16571279 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 16571279 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 7750187 — Biomarker: TG mRNA
Type: Predictive Biomarker (PRD)
Genes: TG
Study 31417681 — Biomarker: Adenosine deaminase
Type: Monitoring Biomarker (MOI)
Genes: ADA; ADA1
Study 16638862 — Biomarker: Interleukin 2
Type: Safety Biomarker (SAF)
Genes: IL2
Study 29169011 — Biomarker: HR mRNA
Type: Predictive Biomarker (PRD)
Genes: HR
Study 29169011 — Biomarker: RPE mRNA
Type: Predictive Biomarker (PRD)
Genes: RPE; HUSSY-17
Study 26792822 — Biomarker: FBP1 mRNA
Type: Predictive Biomarker (PRD)
Genes: FBP1; FBP
Study 22285278 — Biomarker: ALK tyrosine kinase receptor
Type: Predictive Biomarker (PRD)
Genes: ALK
Study 14629852 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 14629852 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 30634203 — Biomarker: SI mRNA
Type: Predictive Biomarker (PRD)
Genes: SI
Study 30634203 — Biomarker: Cystatin C
Type: Safety Biomarker (SAF)
Genes: CST3
Study 23996496 — Biomarker: BDNF mRNA
Type: Predictive Biomarker (PRD); Monitoring Biomarker (MOI)
Genes: BDNF
Study 23996496 — Biomarker: Myeloperoxidase
Type: Safety Biomarker (SAF)
Genes: MPO
Study 23996496 — Biomarker: T-cell specific protein RANTES
Type: Safety Biomarker (SAF)
Genes: CCL5; D17S136E; SCYA5
Study 23996496 — Biomarker: NCAM1 mRNA
Type: Predictive Biomarker (PRD)
Genes: NCAM1; NCAM
Study 18677177 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 18677177 — Biomarker: High density lipoprotein cholesterol
Type: Pharmacodynamic Biomarker (PDY)
Study 18677177 — Biomarker: Low-density lipoprotein
Type: Pharmacodynamic Biomarker (PDY)
Study 12182909 — Biomarker: TAT mRNA
Type: Predictive Biomarker (PRD)
Genes: TAT
Study 12182909 — Biomarker: Antithrombin-III
Type: Safety Biomarker (SAF)
Genes: SERPINC1; AT3; PRO0309
Study 10469772 — Biomarker: White blood cell
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF)
Study 1725549 — Biomarker: Angiotensin-converting enzyme
Type: Pharmacodynamic Biomarker (PDY)
Genes: ACE; DCP; DCP1
Study 17906163 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 9451062 — Biomarker: Pulmonary vascular resistance
Type: Surrogate Endpoint (SUR)
Study 7658056 — Biomarker: CD4 mRNA
Type: Predictive Biomarker (PRD)
Genes: CD4
Study 28830529 — Biomarker: MB mRNA
Type: Predictive Biomarker (PRD)
Genes: MB
Study 25381858 — Biomarker: Eosinophil cationic protein
Type: Safety Biomarker (SAF)
Genes: RNASE3; ECP; RNS3
Study 12882844 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 23185756 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 16335686 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 7787918 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 21460356 — Biomarker: Urinary oxalate
Type: Surrogate Endpoint (SUR)
Study 23928094 — Biomarker: TNF-related weak inducer of apoptosis
Type: Predictive Biomarker (PRD)
Genes: TNFSF12; APO3L; DR3LG; UNQ181/PRO207
Study 23928094 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 23928094 — Biomarker: C-C motif chemokine 2
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: CCL2; MCP1; SCYA2
Study 17545850 — Biomarker: Epidermal growth factor receptor
Type: Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: EGFR; ERBB; ERBB1; HER1
Study 9591926 — Biomarker: Forced vital capacity
Type: Surrogate Endpoint (SUR)
Study 29748350 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 28376921 — Biomarker: Blood pressure
Type: Surrogate Endpoint (SUR)
Study 28631250 — Biomarker: Probing pocket depth
Type: Surrogate Endpoint (SUR)
Study 20386463 — Biomarker: Granulocyte-macrophage colony-stimulating factor
Type: Safety Biomarker (SAF)
Genes: CSF2; GMCSF
Study 16051499 — Biomarker: MIP mRNA
Type: Predictive Biomarker (PRD)
Genes: MIP; AQP0
Study 11518831 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 7933659 — Biomarker: MVP mRNA
Type: Predictive Biomarker (PRD)
Genes: MVP; LRP
Study 30141180 — Biomarker: Serum calcium
Type: Surrogate Endpoint (SUR)
Study 25502081 — Biomarker: Tumor necrosis factor
Type: Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI)
Genes: TNF; TNFA; TNFSF2
Study 27345158 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)
Study 9251452 — Biomarker: Serum creatinine
Type: Surrogate Endpoint (SUR)
Study 17846548 — Biomarker: MVD mRNA
Type: Predictive Biomarker (PRD)
Genes: MVD; MPD
Study 28540893 — Biomarker: Serum sodium
Type: Surrogate Endpoint (SUR)
Study 28540893 — Biomarker: Serum albumin
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study 17000354 — Biomarker: PNOC mRNA
Type: Predictive Biomarker (PRD)
Genes: PNOC; OFQ
Study 10884864 — Biomarker: CP mRNA
Type: Predictive Biomarker (PRD)
Genes: CP
Study 30127143 — Biomarker: GAL3ST1 mRNA
Type: Predictive Biomarker (PRD)
Genes: GAL3ST1; CST
Study 30127143 — Biomarker: Vascular endothelial growth factor
Type: Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY)
Study 12003435 — Biomarker: Bone mineral density
Type: Surrogate Endpoint (SUR)